Hari TulsidasAlzheimer’s disease is a devastating form of dementia affecting millions worldwide. A new drug, called aducanumab, has been approved by the FDA for treating Alzheimer’s. The drug works by clearing the toxic amyloid plaques that build up in the brain and cause memory loss. Many reports appeared last year disputing the amyloid hypothesis. The success of similar drugs in the past has been dismal.
